DE3680099D1 - Zum erkennen von aderverkalkungsschaeden faehiger monoklonaler antikoerper und mittel zum nachweis und zur behandlung von aderverkalkung. - Google Patents

Zum erkennen von aderverkalkungsschaeden faehiger monoklonaler antikoerper und mittel zum nachweis und zur behandlung von aderverkalkung.

Info

Publication number
DE3680099D1
DE3680099D1 DE8686400462T DE3680099T DE3680099D1 DE 3680099 D1 DE3680099 D1 DE 3680099D1 DE 8686400462 T DE8686400462 T DE 8686400462T DE 3680099 T DE3680099 T DE 3680099T DE 3680099 D1 DE3680099 D1 DE 3680099D1
Authority
DE
Germany
Prior art keywords
detecting
scaling
monoclonal antibodies
damage
coral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686400462T
Other languages
English (en)
Inventor
Tatsuya Takano
Ryoichi Hashida
Keiji Nakagami
Junji Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Research Development Corp of Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Corp of Japan filed Critical Research Development Corp of Japan
Application granted granted Critical
Publication of DE3680099D1 publication Critical patent/DE3680099D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE8686400462T 1984-11-30 1986-03-05 Zum erkennen von aderverkalkungsschaeden faehiger monoklonaler antikoerper und mittel zum nachweis und zur behandlung von aderverkalkung. Expired - Lifetime DE3680099D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59252013A JPS61130238A (ja) 1984-11-30 1984-11-30 動脈硬化巣認識モノクロナル抗体および反応試薬
EP86400462A EP0236637B1 (de) 1984-11-30 1986-03-05 Zum Erkennen von Aderverkalkungsschäden fähiger monoklonaler Antikörper und Mittel zum Nachweis und zur Behandlung von Aderverkalkung

Publications (1)

Publication Number Publication Date
DE3680099D1 true DE3680099D1 (de) 1991-08-08

Family

ID=39618879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686400462T Expired - Lifetime DE3680099D1 (de) 1984-11-30 1986-03-05 Zum erkennen von aderverkalkungsschaeden faehiger monoklonaler antikoerper und mittel zum nachweis und zur behandlung von aderverkalkung.

Country Status (5)

Country Link
US (1) US5110738A (de)
EP (2) EP0189688A3 (de)
JP (1) JPS61130238A (de)
CA (1) CA1308677C (de)
DE (1) DE3680099D1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130238A (ja) * 1984-11-30 1986-06-18 Res Dev Corp Of Japan 動脈硬化巣認識モノクロナル抗体および反応試薬
US6025477A (en) * 1986-03-31 2000-02-15 Calenoff; Emanuel Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5811248A (en) * 1986-03-31 1998-09-22 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5955584A (en) * 1986-03-31 1999-09-21 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
EP0248630A3 (de) * 1986-06-06 1990-04-25 Vasocor Immuntest für atherosklerotisches Plaque-Antigen
EP0250119A3 (de) * 1986-06-20 1990-04-18 Vasocor Atherosclerotischer anti-idiotypischer Antikörper, Immunotest und Reagenzien
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
FR2619924B1 (fr) * 1987-08-26 1989-12-29 Diatech Sa Procede de preparation de fractions antigeniques destinees a la detection d'anticorps revelateurs d'un risque cardio-vasculaire, fractions antigeniques ainsi obtenues et leur utilisation pour le diagnostic d'un risque cardio-vasculaire
JP2818658B2 (ja) * 1988-03-03 1998-10-30 達哉 高野 ヒト動脈硬化症認識モノクロナル抗体およびその製造法
CA1320461C (en) * 1988-02-04 1993-07-20 Tatsuya Takano Monoclonal antibody capable of recognizing human arteriosclerosis and process for preparing same
US5726153A (en) * 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5376356A (en) * 1989-03-14 1994-12-27 Neorx Corporation Imaging tissue sites of inflammation
JPH0330085U (de) * 1989-07-31 1991-03-25
US5196324A (en) * 1989-12-15 1993-03-23 Eli Lilly And Company Monoclonal antibodies reactive with a human atheroma associated antigen
WO1991013085A1 (en) * 1990-03-02 1991-09-05 Brigham And Women's Hospital Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
JPH04122977U (ja) * 1991-04-03 1992-11-05 サンデン株式会社 熱交換器
JP4044972B2 (ja) * 1994-02-24 2008-02-06 協和メデックス株式会社 ヒト粥状硬化病巣関連抗原を認識するモノクローナル抗体
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
JP5314242B2 (ja) 2004-04-27 2013-10-16 中外製薬株式会社 プラズマ細胞の増殖方法
EP1874334A4 (de) * 2005-04-15 2011-03-30 Vascular Biogenics Ltd Zusammensetzungen mit von beta 2-glykoprotein i stammenden peptiden zur prävention und/oder behandlung von gefässerkrankungen
ITUA20161994A1 (it) * 2016-03-24 2017-09-24 Azienda Ospedaliera Univ Senese Uso degli inibitori ddx3 come agenti anti-iperproliferativi

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130238A (ja) * 1984-11-30 1986-06-18 Res Dev Corp Of Japan 動脈硬化巣認識モノクロナル抗体および反応試薬

Also Published As

Publication number Publication date
EP0189688A2 (de) 1986-08-06
JPS61130238A (ja) 1986-06-18
EP0189688A3 (de) 1988-03-16
EP0236637B1 (de) 1991-07-03
EP0236637A1 (de) 1987-09-16
US5110738A (en) 1992-05-05
JPH0254078B2 (de) 1990-11-20
CA1308677C (en) 1992-10-13

Similar Documents

Publication Publication Date Title
DE3680099D1 (de) Zum erkennen von aderverkalkungsschaeden faehiger monoklonaler antikoerper und mittel zum nachweis und zur behandlung von aderverkalkung.
AT378910B (de) Verfahren und mittel zur behandlung keratinischer substanzen
IT1209572B (it) Composizione e procedimento per il trattamento dei capelli.
DE3482076D1 (de) Plasmabearbeitungsverfahren und geraet zur anwendung dieses verfahrens.
DE3583595D1 (de) Verfahren und vorrichtung zur behandlung von abfallmaterial.
AT363613B (de) Verfahren und mittel zur beseitigung von truebungen
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3583942D1 (de) Verfahren zur behandlung von fluiden.
DE3152893A1 (de) Verfahren und zusammensetzung zur behandlung von akne
DE3775597D1 (de) Vorrichtung zur behandlung von teilchenfoermigem material.
DE3752141D1 (de) Mittel zur behandlung von neuropathie
DE3782801D1 (de) Verfahren zur schlagfeld-freund-feind-kennung und system zum ausfuehren davon.
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE3585160D1 (de) Verfahren zur behandlung von schmelzverarbeitbaren copolymeren von tetrafluoraethylen und perfluoralkylvinylaether.
DE3687512D1 (de) Verfahren und vorrichtung zur behandlung von schlaemmen.
DE3382699D1 (de) Verfahren zur bildkontrasterhoehung und materialien dazu.
DE69108557D1 (de) Verfahren und apparat zur dehydrogenierung von alkanen.
DE3788973D1 (de) Verfahren und Vorrichtung zur Handhabung und Behandlung von scheibenartigen Materialien.
DE3481977D1 (de) Elektroimpulsverfahren und vorrichtung zur behandlung von stoffen.
DE58901593D1 (de) Verfahren und einrichtung zur thermischen behandlung von abfallstoffen.
DE3668473D1 (de) Verfahren zur behandlung von oberflaechen und apparatur dafuer.
DE3668172D1 (de) Verfahren zur behandlung von aktiviertem siliciumpulver.
DE3482862D1 (de) Verfahren zum behandeln von silicium und ferrosilicium mit schlacke.
DE3667926D1 (de) Verfahren und mittel zur wasserbehandlung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition